Patent · US Active

Compounds

US8877742B2 · kind B2 · utility

1Cited by
1References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 8, 2012
Grant dateNov 4, 2014
Priority date
Expiry dateJun 8, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to novel NADPH oxidase II inhibitors and their use in the treatment of diseases mediated by the NADPH oxidase enzymes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.